ARTL logo

Artelo Biosciences (ARTL) Company Overview

Profile

Full Name:

Artelo Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 21, 2019

Indexes:

Not included

Description:

Artelo Biosciences (ARTL) is a biotechnology company focused on developing innovative therapies for serious medical conditions. They aim to improve patient outcomes by researching and creating new treatments, particularly in the areas of cancer and pain management, using advanced science and technology.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 10, 2022

Analyst ratings

Recent major analysts updates

Mar 4, 25 HC Wainwright & Co.
Buy
Mar 3, 25 D. Boral Capital
Buy
Feb 27, 25 D. Boral Capital
Buy
Jan 14, 25 D. Boral Capital
Buy
Dec 9, 24 HC Wainwright & Co.
Buy
Dec 9, 24 D. Boral Capital
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
Jun 5, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 2, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Artelo Biosciences?
  • Does Artelo Biosciences pay dividends?
  • What sector is Artelo Biosciences in?
  • What industry is Artelo Biosciences in?
  • What country is Artelo Biosciences based in?
  • When did Artelo Biosciences go public?
  • Is Artelo Biosciences in the S&P 500?
  • Is Artelo Biosciences in the NASDAQ 100?
  • Is Artelo Biosciences in the Dow Jones?
  • When does Artelo Biosciences report earnings?
  • Should I buy Artelo Biosciences stock now?

What is the ticker symbol for Artelo Biosciences?

The ticker symbol for Artelo Biosciences is NASDAQ:ARTL

Does Artelo Biosciences pay dividends?

No, Artelo Biosciences does not pay dividends

What sector is Artelo Biosciences in?

Artelo Biosciences is in the Healthcare sector

What industry is Artelo Biosciences in?

Artelo Biosciences is in the Biotechnology industry

What country is Artelo Biosciences based in?

Artelo Biosciences is headquartered in United States

When did Artelo Biosciences go public?

Artelo Biosciences's initial public offering (IPO) was on June 21, 2019

Is Artelo Biosciences in the S&P 500?

No, Artelo Biosciences is not included in the S&P 500 index

Is Artelo Biosciences in the NASDAQ 100?

No, Artelo Biosciences is not included in the NASDAQ 100 index

Is Artelo Biosciences in the Dow Jones?

No, Artelo Biosciences is not included in the Dow Jones index

When does Artelo Biosciences report earnings?

The date for Artelo Biosciences's next earnings report has not been announced yet

Should I buy Artelo Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions